Christoph Binder

Christoph J. Binder (born 1973) received his MD degree from the University of Vienna, Austria, in 1997 and his PhD degree in Molecular Pathology from the University of California San Diego (UCSD), USA, in 2002. Following postdoctoral training at the Department of Medicine of UCSD, he established his own research group at the Department of Laboratory Medicine of the Medical University of Vienna in 2005. In 2009, he was appointed Full Professor of Atherosclerosis Research at the Medical University of Vienna. He is a specialist in Laboratory Medicine and currently Deputy Head of the Department of Laboratory Medicine at the Medical University of Vienna. Between 2006 until 2021 he was Principal Investigator at the Center for Molecular Medicine of the Austrian Academy of Sciences.

Christoph Binder’s research interests span the interface of vascular biology, lipid oxidation, and immunity. His group is investigating immune mechanisms of atherosclerosis with a special focus on the role of innate and humoral immunity and how this can be exploited for the treatment of cardiovascular disease. Christoph Binder has won numerous prestigious fellowships and awards and has authored >200 original and review papers in important international journals, including Nature and Nature Medicine. He is Co-Editor of Atherosclerosis and Section Editor of Thrombosis & Haemostasis, and since 2017 PI of the Austrian Familial Hypercholesterolemia Registry. Since 2024 he acts as Vice President for Biology and Medicine of the Austrian Science Fund.